(Q44665402)

English

Salvage chemotherapy for refractory or relapsed post-transplant lymphoproliferative disorder in patients after solid organ transplantation with a combination of carboplatin and etoposide

scientific article published in December 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Salvage chemotherapy for refractory or relapsed post-transplant lymphoproliferative disorder in patients after solid organ transplantation with a combination of carboplatin and etoposide (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

post-transplant lymphoproliferative disorder

0 references

organ transplantation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Stephan H Oertel

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Matthias Papp-Váry

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Ioannis Anagnostopoulos

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Manfred W Hummel

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sven Jonas

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Hanno B Riess

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

0 references

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

123

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

830-835

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04705.X

21 January 2018

Interferon and cytotoxic chemotherapy for the treatment of post-transplant lymphoproliferative disorder

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04705.X

21 January 2018

Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04705.X

21 January 2018

Identification of early antigen BZLF1/ZEBRA protein of Epstein-Barr virus can predict the effectiveness of antiviral treatment in patients with post-transplant lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04705.X

21 January 2018

Adverse reactions and interactions of cyclosporin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04705.X

21 January 2018

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04705.X

21 January 2018

Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04705.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2003.04705.X

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44665402&oldid=2031216682"